These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 19190159
1. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Kim Y, Park SK, Han W, Kim DH, Hong YC, Ha EH, Ahn SH, Noh DY, Kang D, Yoo KY. Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):508-15. PubMed ID: 19190159 [Abstract] [Full Text] [Related]
2. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, Orentreich N. Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):483-8. PubMed ID: 9641492 [Abstract] [Full Text] [Related]
3. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I. J Natl Cancer Inst; 2004 Aug 04; 96(15):1152-60. PubMed ID: 15292387 [Abstract] [Full Text] [Related]
4. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Han S, Lee KM, Choi JY, Park SK, Lee JY, Lee JE, Noh DY, Ahn SH, Han W, Kim DH, Hong YC, Ha E, Yoo KY, Kang D. Breast Cancer Res Treat; 2008 Jul 04; 110(2):387-93. PubMed ID: 17940865 [Abstract] [Full Text] [Related]
5. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Nichols HB, Trentham-Dietz A, Love RR, Hampton JM, Hoang Anh PT, Allred DC, Mohsin SK, Newcomb PA. Cancer Epidemiol Biomarkers Prev; 2005 Jan 04; 14(1):41-7. PubMed ID: 15668474 [Abstract] [Full Text] [Related]
6. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE. Cancer Epidemiol Biomarkers Prev; 2006 May 04; 15(5):967-71. PubMed ID: 16702378 [Abstract] [Full Text] [Related]
7. Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project. Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP. Prev Med; 2000 Oct 04; 31(4):335-45. PubMed ID: 11006058 [Abstract] [Full Text] [Related]
8. The association of carbohydrate intake, glycemic load, glycemic index, and selected rice foods with breast cancer risk: a case-control study in South Korea. Yun SH, Kim K, Nam SJ, Kong G, Kim MK. Asia Pac J Clin Nutr; 2010 Oct 04; 19(3):383-92. PubMed ID: 20805083 [Abstract] [Full Text] [Related]
9. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Rusiecki JA, Holford TR, Zahm SH, Zheng T. Cancer Detect Prev; 2005 Oct 04; 29(5):419-26. PubMed ID: 16185815 [Abstract] [Full Text] [Related]
10. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study. Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Yoo KY, Kang D. BMC Cancer; 2005 Oct 31; 5():143. PubMed ID: 16259637 [Abstract] [Full Text] [Related]
11. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Cancer Res; 2004 Sep 15; 64(18):6814-9. PubMed ID: 15375001 [Abstract] [Full Text] [Related]
12. Dietary patterns and breast cancer risk in Korean women. Cho YA, Kim J, Shin A, Park KS, Ro J. Nutr Cancer; 2010 Sep 15; 62(8):1161-9. PubMed ID: 21058205 [Abstract] [Full Text] [Related]
13. Anthropometric measures, plasma adiponectin, and breast cancer risk. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA. Endocr Relat Cancer; 2007 Sep 15; 14(3):669-77. PubMed ID: 17914097 [Abstract] [Full Text] [Related]
14. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study. Deandrea S, Talamini R, Foschi R, Montella M, Dal Maso L, Falcini F, La Vecchia C, Franceschi S, Negri E. Cancer Epidemiol Biomarkers Prev; 2008 Aug 15; 17(8):2025-8. PubMed ID: 18708394 [Abstract] [Full Text] [Related]
15. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. J Clin Oncol; 2007 Apr 20; 25(12):1482-8. PubMed ID: 17372279 [Abstract] [Full Text] [Related]
16. Adipocytokines and breast cancer risk. Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, Sun Y, Wu Q, Chen L. Chin Med J (Engl); 2007 Sep 20; 120(18):1592-6. PubMed ID: 17908478 [Abstract] [Full Text] [Related]
17. Progestagens use before menopause and breast cancer risk according to histology and hormone receptors. Fabre A, Fournier A, Mesrine S, Gompel A, Desreux J, Berrino F, Boutron-Ruault MC, Romieu I, Clavel-Chapelon F. Cancer Epidemiol Biomarkers Prev; 2008 Oct 20; 17(10):2723-8. PubMed ID: 18843015 [Abstract] [Full Text] [Related]
18. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE. Cancer Epidemiol Biomarkers Prev; 2007 Jan 20; 16(1):161-4. PubMed ID: 17220346 [Abstract] [Full Text] [Related]
19. Significance of alterations in plasma lipid profile levels in breast cancer. Franky Dhaval Shah, Shilin Nandubhai Shukla, Pankaj Manubhai Shah, Patel HR, Prabhudas Shankerbhai Patel. Integr Cancer Ther; 2008 Mar 20; 7(1):33-41. PubMed ID: 18292593 [Abstract] [Full Text] [Related]
20. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, Goodwin PJ. Breast Cancer Res Treat; 2005 Nov 20; 94(2):135-44. PubMed ID: 16261412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]